X @Bloomberg
Bloomberg·2026-02-05 01:32
Eikon Therapeutics, a late-stage cancer drug developer led by Merck veterans, raised $381.2 million in an upsized US initial public offering https://t.co/ETqqNtgxuj ...
Eikon Therapeutics, a late-stage cancer drug developer led by Merck veterans, raised $381.2 million in an upsized US initial public offering https://t.co/ETqqNtgxuj ...